← Back to headlines
Telix Pharmaceuticals Appoints David Gill as Board Chairman
The nuclear medicine company has named industry veteran David Gill to lead its board of directors, aiming to strengthen governance and strategic oversight.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
